Michael Kharouta

469 total citations
34 papers, 321 citations indexed

About

Michael Kharouta is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Kharouta has authored 34 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Kharouta's work include Breast Cancer Treatment Studies (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Michael Kharouta is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Michael Kharouta collaborates with scholars based in United States, Lebanon and Canada. Michael Kharouta's co-authors include Claire F. Honeycutt, Eric J. Perreault, Abraham Kim, Kevin Miller, Arunangsu Dey, German Kilimnik, Donald F. Steiner, P. Wójcik, Manami Hara and Mitchell Machtay and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Journal of Neurophysiology.

In The Last Decade

Michael Kharouta

29 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Kharouta United States	8	93	67	64	59	46	34	321
Zbyněk Tüdös Czechia	13	75 0.8×	62 0.9×	29 0.5×	48 0.8×	12 0.3×	49	369
Chandrasekhar Bal India	11	103 1.1×	70 1.0×	53 0.8×	51 0.9×	10 0.2×	35	398
Francisco Javier García Gómez Spain	10	62 0.7×	42 0.6×	47 0.7×	75 1.3×	9 0.2×	86	483
Kun Lv China	12	72 0.8×	74 1.1×	33 0.5×	148 2.5×	15 0.3×	48	438
Ju Won Seok South Korea	13	123 1.3×	64 1.0×	19 0.3×	87 1.5×	12 0.3×	45	400
Anil Mahavadi United States	13	52 0.6×	95 1.4×	15 0.2×	42 0.7×	50 1.1×	33	387
M Escudero Spain	8	77 0.8×	19 0.3×	40 0.6×	53 0.9×	33 0.7×	17	370
Jane Halliday United Kingdom	10	139 1.5×	22 0.3×	22 0.3×	49 0.8×	15 0.3×	32	427
Oğuz Baran Türkiye	11	74 0.8×	33 0.5×	20 0.3×	52 0.9×	35 0.8×	57	375
Luciano Farage Brazil	12	51 0.5×	65 1.0×	48 0.8×	66 1.1×	5 0.1×	30	335

Countries citing papers authored by Michael Kharouta

Since Specialization

Citations

This map shows the geographic impact of Michael Kharouta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kharouta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kharouta more than expected).

Fields of papers citing papers by Michael Kharouta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kharouta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kharouta. The network helps show where Michael Kharouta may publish in the future.

Co-authorship network of co-authors of Michael Kharouta

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kharouta. A scholar is included among the top collaborators of Michael Kharouta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kharouta. Michael Kharouta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gross, Andrew, Saad Sheikh, Michael Kharouta, et al.. (2023). The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series. Clinical Lung Cancer. 24(8). 696–705. 4 indexed citations

Kharouta, Michael, Eleanor Harris, Robert Shenk, et al.. (2023). Reduced-Dose Radiation Therapy and Concurrent Paclitaxel Chemotherapy in Lymph Node-Positive Breast Cancer: Long-Term Follow-up of a Single-Institution Prospective Study. International Journal of Radiation Oncology*Biology*Physics. 117(4). 883–886.

Kharouta, Michael, et al.. (2022). Dehydration Reduction in Head and Neck Cancer (DRIHNC) Trial: Daily Oral Fluid and Electrolyte Maintenance to Prevent Acute Care Clinic and Emergency Department Visits for Patients Receiving Radiation for Head and Neck and Esophageal Cancer. Advances in Radiation Oncology. 7(6). 101026–101026.

Kharouta, Michael, et al.. (2022). Partial Breast Reirradiation for Patients With Ipsilateral Breast Tumor Recurrence After Initial Treatment With Breast Conservation for Early Stage Breast Cancer. Practical Radiation Oncology. 12(6). e493–e500. 3 indexed citations

Grubb, William, Michael Kharouta, Yuxia Zhang, et al.. (2022). A Comparative Study of Patients With Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy Using CyberKnife and Linear Accelerator–Based Volumetric Modulated Arc Therapy. Practical Radiation Oncology. 12(3). 200–209. 1 indexed citations

Cao, Lifen, et al.. (2022). Trends in surgery and survival for T1-T2 male breast cancer: A study from the National Cancer Database. The American Journal of Surgery. 225(1). 75–83. 6 indexed citations

Chen, Eric, Michael Kharouta, Tithi Biswas, et al.. (2022). An Analysis of Cancer Center–Provided Rideshare Utilization for Radiation Therapy. Journal of the American College of Radiology. 20(1). 40–50. 14 indexed citations

Traughber, Bryan, Michael Kharouta, Tarun K. Podder, et al.. (2021). Focal Prostate Stereotactic Body Radiation Therapy With Correlative Pathological and Radiographic-Based Treatment Planning. Frontiers in Oncology. 11. 744130–744130. 3 indexed citations

Kharouta, Michael, Nirav Patil, Pedro A. Torres‐Saavedra, et al.. (2021). 863MO Nomogram for predicting survival for patients receiving definitive chemoradiation in locally advanced squamous cell carcinoma of the head and neck: A secondary analysis of NRG/RTOG 0129, 0522, and 1016. Annals of Oncology. 32. S788–S788. 2 indexed citations

10.

Kharouta, Michael, et al.. (2021). Telemedicine Use and Satisfaction Among Radiation Oncologists During the COVID-19 Pandemic: Evaluation of Current Trends and Future Opportunities. Advances in Radiation Oncology. 7(2). 100835–100835. 19 indexed citations

11.

Healy, Erin, Michael Kharouta, Jennifer A. Sipos, et al.. (2021). Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study. Technical Innovations & Patient Support in Radiation Oncology. 20. 28–34.

12.

Kharouta, Michael, Rajesh Pidikiti, Mark C. Smith, et al.. (2021). Proton Beam Therapy in the Treatment of Periorbital Malignancies. International Journal of Particle Therapy. 7(4). 42–51. 2 indexed citations

13.

Davison, Mark A., Michael Kharouta, J Turian, et al.. (2020). Heart dose and coronary artery calcification in patients receiving thoracic irradiation for lung cancer. Journal of Thoracic Disease. 12(3). 223–231. 8 indexed citations

14.

Grubb, William, Lee Ponsky, Simon S. Lo, et al.. (2020). Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma. Radiotherapy and Oncology. 155. 138–143. 30 indexed citations

15.

Pidikiti, Rajesh, Michael Kharouta, Mark C. Smith, et al.. (2019). Reirradiation for Recurrent Scalp Angiosarcoma: Dosimetric Advantage of PBT over VMAT and EBT. International Journal of Particle Therapy. 6(3). 13–18. 3 indexed citations

16.

Kharouta, Michael, William Grubb, Tarun K. Podder, & Tithi Biswas. (2019). Use of surgery and stereotactic body radiotherapy (SBRT) in very elderly patients with early-stage non-small cell lung cancer (NSCLC): A national cancer database (NCDB) analysis.. Journal of Clinical Oncology. 37(15_suppl). e20058–e20058. 1 indexed citations

17.

Kharouta, Michael, et al.. (2018). Initial experience using superflab as intravaginal packing during interstitial brachytherapy for advanced gynecologic cancer. Journal of Contemporary Brachytherapy. 10(3). 218–224. 1 indexed citations

18.

Kharouta, Michael, Nghia H. Pham, Murat Sürücü, et al.. (2018). Comparison of dosimetric and clinical outcomes between short- and long-channel cylinder applicators for vaginal brachytherapy in intermediate- and high-risk endometrial cancer. Brachytherapy. 17(4). 673–679. 3 indexed citations

19.

AlJaroudi, Wael, Ibtihaj Fughhi, Aviral Vij, et al.. (2017). The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation. Journal of Nuclear Cardiology. 26(3). 814–822. 11 indexed citations

20.

Fughhi, Ibtihaj, et al.. (2017). THE PROGNOSTIC VALUE OF SERIAL STRESS MYOCARDIAL PERFUSION IMAGING IN ASYMPTOMATIC END-STAGE RENAL DISEASE PATIENTS AWAITING KIDNEY TRANSPLANTATION. Journal of the American College of Cardiology. 69(11). 1482–1482. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact